Page last updated: 2024-09-02

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bok, E; Chung, YC; Huh, SH; Jin, BK; Kim, SR; Kim, YS; Maeng, S; Park, JY; Park, SH; Yoon, SH1

Other Studies

1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

ArticleYear
Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation.
    Journal of immunology (Baltimore, Md. : 1950), 2011, Dec-15, Volume: 187, Issue:12

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Benzoxazines; Cells, Cultured; Coculture Techniques; Corpus Striatum; Dopamine Agents; Dronabinol; Growth Inhibitors; Male; Mice; Mice, Inbred C57BL; Microglia; Morpholines; Naphthalenes; Neurons; Neurotoxins; Parkinsonian Disorders; Receptor, Cannabinoid, CB1; Substantia Nigra

2011